(Q39474501)

12 September 2017

In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori (English)

1 reference

12 September 2017

0 references

1 reference

1 reference

1 reference

1 reference

A M Hirschl

1

1 reference

12 September 2017

P Apfalter

2

1 reference

12 September 2017

A Makristathis

3

1 reference

12 September 2017

M L Rotter

4

1 reference

12 September 2017

M Wimmer

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Antimicrobial Agents and Chemotherapy

12 September 2017

1 reference

12 September 2017

44

1 reference

12 September 2017

7

1 reference

12 September 2017

1977-1979

1 reference

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

Antibiotic resistance in Helicobacter pylori: implications for therapy.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

Gastric diffusion of antibiotics used against Helicobacter pylori

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

Will Helicobacter pylori be the next organism for which we will have exhausted our treatment options?

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89996

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10858365

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10858365

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10858365

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.44.7.1977-1979.2000

1 reference

release_chsjltlzk5hrtpxqs4tnyclrdm

12 September 2017

0 references

1 reference

12 September 2017

PubMed publication ID

10858365

1 reference